SIRT6 increases life expectancy by an average of 30%

SIRT6 increases life expectancy by an average of 30%

Aging is associated with an overall decline in health and increased frailty, and is a major risk factor for multiple chronic diseases. Frailty syndrome, characterized by weakness, fatigue and low physical activity, affects more than 30% of the elderly population. Increasing our understanding of the mechanisms underlying the aging process is a top priority to facilitate the development of interventions that will lead to the preservation of health and improvements on survival and lifespan.

Cumulative evidence suggests that diet and metabolism are key targetable regulators of healthy lifespan. In a study just published in the journal Nature Communications, an international team report that transgenic mice express high levels of the SIRT6 gene, and show that their life expectancy can be increased by an average of 30% in both males and females. Translated into human terms this means that a 90-year-old could live until nearly 120!

Furthermore, the mice exhibited significant improvement in overcoming a variety of age-related diseases, such as cancer and blood disorders. Beyond this, strikingly, they were able to conduct the same level of vigorous activity as young mice, and didn't become frail.

Next, through a variety of biochemical methods and metabolic analyses the researchers deciphered the mechanism through which SIRT6 acts as a type of "fountain of youth", facilitating healthy aging.

They showed that older animals lose the ability to generate energy in the absence of external energy sources, such as a short fast. On the other hand, the engineered mice maintained an enhanced energy generation capacity from other storage, such as the breakdown of fats and lactic acid. By doing so, they created sugar utilized for energy in muscle and specifically in the brain. In fact SIRT6 activates a physical response that is identical to diets that increase longevity.

"This discovery, combined with our previous findings, shows that SIRT6 controls the rate of healthy aging," says the senior author. "If we can determine how to activate it in humans, we will be able to prolong life, and this could have enormous health and economic implications."